Atomic-scale imperfections in graphene transistors generate unique wireless fingerprints that cannot be copied or predicted, ...
Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization ...
A major British research university’s joint venture campus in China maintains partnerships and close links with entities ...
Modalis Therapeutics Corporation (TOKYO: 4883) today announced that its research article titled "Efficient LAMA1 gene activation by epigenome editing as a therapeutic approach for LAMA2-CMD" has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback